Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.
Affordable strategies to prevent treatment failure on first-line regimens among HIV patients are essential for the long-term success of antiretroviral therapy (ART) in sub-Saharan Africa. WHO recommends using routinely collected data such as adherence to drug-refill visits as early warning indicator...
Main Authors: | Ziad El-Khatib, David Katzenstein, Gaetano Marrone, Fatima Laher, Lerato Mohapi, Max Petzold, Lynn Morris, Anna Mia Ekström |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-03-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3052314?pdf=render |
Similar Items
-
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study
by: Katzenstein David, et al.
Published: (2011-02-01) -
Gender perspective of risk factors associated with disclosure of HIV status, a cross-sectional study in Soweto, South Africa.
by: Elisa Longinetti, et al.
Published: (2014-01-01) -
An Exploratory Model of Medication Refill Adherence Behavior
by: Payne, Gayle Holmes
Published: (2009) -
Utilization of social media and web forums by HIV patients - A cross-sectional study on adherence and reported anxiety level
by: Elisa Longinetti, et al.
Published: (2017-06-01) -
Virological and Immunological Aspects of AIDS Pathogenesis
by: Brian Conway, et al.
Published: (1994-01-01)